Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Crowther

Showing results (61-70 of 286) with videos related to

Pageof 29
Sort By:
Thrombosis Research|September 24, 2014
Rofecoxib does not appear to increase the risk of venous thromboembolism: a systematic review of the literatureJennifer Goy, Jeremy Paikin, Mark Crowther
Archives of Internal Medicine|December 3, 2002
Is impaired renal function a contraindication to the use of low-molecular-weight heparin?Jeff Nagge, Mark Crowther, Jack Hirsh
Seminars in Hematology|May 14, 2013
Thrombopoietin receptor agonists in primary immune thrombocytopeniaDeborah Siegal, Mark Crowther, Adam Cuker
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assaysAnne Raby, Karen Moffat, Mark Crowther
BMJ (Clinical Research Ed.)|May 27, 2017
Specific antidotes for bleeding associated with direct oral anticoagulantsAllison Burnett, Deborah Siegal, Mark Crowther
The New England Journal of Medicine|April 20, 2012
Iron overload in human diseaseZain Kassam, Paul Moayyedi, Mark Crowther
Blood|January 7, 2006
Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysisFrancesco Dentali, Mark Crowther, Walter Ageno
Pharmacoeconomics|June 10, 2006
Dalteparin versus warfarin for the prevention of recurrent venous thromboembolic events in cancer patients: a pharmacoeconomic analysisGeorge Dranitsaris, Mark Vincent, Mark Crowther
Research and Practice in Thrombosis and Haemostasis|April 17, 2023
Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosingThita Chiasakul, Mark Crowther, Adam Cuker
Blood|June 13, 2009
A case of apples and pears?Mark Crowther, Mark A Vickers, Alison Avenell
Pageof 29

Showing results (61-70 of 286) with videos related to

Sort By:
Pageof 29
Thrombosis Research|September 24, 2014
Rofecoxib does not appear to increase the risk of venous thromboembolism: a systematic review of the literatureJennifer Goy, Jeremy Paikin, Mark Crowther
Archives of Internal Medicine|December 3, 2002
Is impaired renal function a contraindication to the use of low-molecular-weight heparin?Jeff Nagge, Mark Crowther, Jack Hirsh
Seminars in Hematology|May 14, 2013
Thrombopoietin receptor agonists in primary immune thrombocytopeniaDeborah Siegal, Mark Crowther, Adam Cuker
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assaysAnne Raby, Karen Moffat, Mark Crowther
BMJ (Clinical Research Ed.)|May 27, 2017
Specific antidotes for bleeding associated with direct oral anticoagulantsAllison Burnett, Deborah Siegal, Mark Crowther
The New England Journal of Medicine|April 20, 2012
Iron overload in human diseaseZain Kassam, Paul Moayyedi, Mark Crowther
Blood|January 7, 2006
Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysisFrancesco Dentali, Mark Crowther, Walter Ageno
Pharmacoeconomics|June 10, 2006
Dalteparin versus warfarin for the prevention of recurrent venous thromboembolic events in cancer patients: a pharmacoeconomic analysisGeorge Dranitsaris, Mark Vincent, Mark Crowther
Research and Practice in Thrombosis and Haemostasis|April 17, 2023
Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosingThita Chiasakul, Mark Crowther, Adam Cuker
Blood|June 13, 2009
A case of apples and pears?Mark Crowther, Mark A Vickers, Alison Avenell
Pageof 29